AP Photo 7 months ago

Former FDA Commissioner David Kessler holds up a piece of carrot cake at a bakery near his home in San Francisco, Monday, April 20, 2009. Kessler has a new book out on addiction-like overeating.

AP Photo 7 months ago

Former FDA Commissioner David Kessler poses at his home in San Francisco, Monday, April 20, 2009. Kessler has a new book out on addiction-like overeating. His research highlights a food industry-driven environment that hijacks people's brains with high-fat, high-sugar foods.

AP Photo 7 months ago

Former FDA Commissioner David Kessler poses at his home in San Francisco, Monday, April 20, 2009. Kessler has a new book out on addiction-like overeating. His research highlights a food industry-driven environment that hijacks people's brains with high-fat, high-sugar foods.

AP Photo 8 months ago

The FDA-cleared, clinically proven ThermaClear(R) Acne Clearing Device delivers a controlled, 2-second pulse of targeted heat directly to individual pimples. The patented Thermal Pulse Technology(TM) clears pimples often in as little as 24 hours.

AP Photo 9 months ago

Former FDA Commissioner Joins Greenleaf Health LLC -- Dr. Andrew von Eschenbach, who resigned last month as FDA Commissioner, has joined Greenleaf Health, a regulatory consulting firm with offices in New York and Washington, DC.

AP Photo 10 months ago

From left, Food and Drug Administration (FDA) Director of the Center for Food Safety and Applied Nutrition Dr. Stephen Sundlof,Regional FDA Director Michael Chappell, Georgia Department of Agriculture Consumer Protection Division Oscar Garrison, J. Leek Associates, Inc.

AP Photo 11 months ago

Cumberland Pharmaceuticals Reports FDA Approval for Updated Labeling of Acetadote(R).

AP Photo 6 days ago

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.

AP Photo 6 days ago

St. Jude Medical, Inc. today announced the U.S. Food and Drug Administration (FDA) approval and U.S. market introduction of its new Penta(TM) surgical lead for neurostimulation therapy.

AP Photo 3 weeks ago

From left, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention Director Dr. Anne Schuchat; Assistant Health and Human Services Secretary for Preparedness and Response Dr. Nicole Lurie; and Food and Drug Administration Acting Chief Scient...

AP Photo 3 weeks ago

Food and Drug Administration Acting Chief Scientist Dr. Jesse Goodman, right, accompanied by Assistant Health and Humans Services Secretary for Preparedness and Response Dr. Nicole Lurie, testifies on Capitol Hill in Washington, Wednesday, Nov. 18, 2009, before the joint House Health an...

AP Photo 3 weeks ago

Assistant Health and Humans Services Secretary for Preparedness and Response Dr. Nicole Lurie, left, accompanied by Food and Drug Administration Acting Chief Scientist Dr. Jesse Goodman, testifies on Capitol Hill in Washington, Wednesday, Nov. 18, 2009, before the joint House Health and...

AP Photo 3 weeks ago

St. Jude Medical, Inc. announced today that a 62-year-old man from Shenzhen, Guangdong province has become the first patient in China to be implanted with the Eon(TM) neurostimulator, a rechargeable device used to help manage chronic pain.

Cell Culture Manager Sanaz Arenivas lifts a rack containing vials of frozen cells used for cloning cattle and other livestock from a liquid nitrogen vapor tank in a cloning lab at ViaGen in Austin, Texas November 11, 2009.

Embryo culture plates sit inside an incubator inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

Cell culture manager Sanaz Arenivas displays cells used for cloning cattle and other livestock inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

Embryologist Fernando Arenivas (L) and Director of Assisted Reproductive Technologies Shu-hung Chen work on the second step of the cloning process called reconstruction where a cell is inserted inside a membrane at ViaGen in Austin, Texas November 11, 2009.

A shock of electro-fusion is used to make a cell fuse with the cytoplasm of an egg inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

Embryologist Fernando Arenivas gives cells a shock of electrofusion, which allows the cell to fuse with the cytoplasm of the egg, inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

An embryologist prepares cells for reconstruction inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

Frozen cells used for cloning cattle and other livestock are stored inside a freezer at ViaGen in Austin, Texas November 11, 2009. ViaGen, along with its partner company, Trans Ova Genetics of Sioux Center, Iowa, produces the vast majority of the clones in the United States.

The calf Elvis is pictured in this undated photograph released on November 12, 2009. Animal cloning and genomics services company ViaGen produced Elvis in 2005 by cloning a Prime Yield Grade 1 Angus crossbred steer using a cell taken from its carcass.

A dish of cells that have fused with the cytoplasm of an egg are seen inside a cloning lab at ViaGen in Austin, Texas November 11, 2009.

K.C. , the first animal produced by cloning from a cell taken from a carcass, is pictured in this undated photograph released by animal cloning and genomics services company ViaGen on November 12, 2009.

Farm workers Ricardo Visconti (L) and Ruben Perez hold Jersey transgenic cows, four-year-old Pampa Victoria and two-year-old Pampa Argentina respectively, in Buenos Aires in this April 17, 2007 file photo.